Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35388, first published .
Inpatient Teledermatology Referrals During the COVID-19 Pandemic in a UK Trust: A Comparative Review and Doctor Survey

Inpatient Teledermatology Referrals During the COVID-19 Pandemic in a UK Trust: A Comparative Review and Doctor Survey

Inpatient Teledermatology Referrals During the COVID-19 Pandemic in a UK Trust: A Comparative Review and Doctor Survey

Authors of this article:

Lucy Howard 1 Author Orcid Image ;   O Jagun 1 ;   A Hong 1 Author Orcid Image ;   Z Hassan 2 Author Orcid Image ;   C Wong 1 ;   S Halpern 1

Abstract

1East Kent Hospitals NHS Foundation Trust, Canterbury, United Kingdom

2Barts Health NHS Trust, London, United Kingdom

Corresponding Author:

Lucy Howard, MBChB

East Kent Hospitals NHS Foundation Trust

Kent and Canterbury Hospital, Ethelbert Road

Canterbury, CT1 3NG

United Kingdom

Phone: 44 01227 766 877

Email: lucy.howard3@nhs.net


Background: The COVID-19 pandemic has broadened the scope of teledermatology services in the United Kingdom from a primarily outpatient-based triage tool to the management of inpatient referrals. In order to reduce the risk of transmission in hospital, a number of changes were implemented within our department. As part of this, our on-call referrals were transferred to a telemedicine app, which incorporates the secure transfer of user-generated patient images onto a web-based image management system providing remote access for the dermatology team.

Objective: This study aimed to compare how the introduction of this referral method impacted the nature and number of referrals received, the efficiency of the on-call service, and user preferences.

Methods: A retrospective cohort study was conducted to compare the number of referrals, time taken to review, and referral diagnoses between previous referral methods to the dermatology department (bleep, fax, email) (July and September 2019) and the new teledermatology app (July and September 2020). We also performed a survey of junior doctors, seeking their feedback and preferences pertaining to the new referral system.

Results: The number of referrals increased by 80%, with a 6-fold increase in lesion referrals. There is a possibility that not all referrals from 2019 were accounted for as paper documents are easily lost or discarded, highlighting another advantage of teledermatology in providing a reliable record of referrals. Dermatology referrals may have increased as the telemedicine app is more accessible to staff across sites. The telemedicine app also led to a reduction in time to review by 0.53 days, resulting in a significantly higher number of patients being given dermatology input on the day of the referral (78% vs 58%). This will have led to earlier treatment, improved patient outcomes, and shorter inpatient stays, resulting in potential cost reductions for the hospital. The survey of junior doctors showed that 81% preferred teledermatology to the previous referral methods.

Conclusions: The introduction of teledermatology has provided an effective and acceptable method of managing on-call dermatology referrals. Easier access to dermatology advice via teledermatology may result in higher numbers of referrals, which may warrant strict referral criteria to prevent oversubscription of the on-call service. Teledermatology ensures an accurate log of referrals, including the nature of referrals, allowing for better auditing and service improvement. Teledermatology referrals allow for advice to be provided within shorter time frames compared to previous methods. This should improve patient outcomes and reduce hospital admission stays, potentially resulting in cost savings for the hospital.

Conflict of Interest: None declared.

iproc 2021;7(1):e35388

doi:10.2196/35388

Keywords


Edited by T Derrick; This is a non–peer-reviewed article. submitted 02.12.21; accepted 03.12.21; published 10.12.21

Copyright

©Lucy Howard, O Jagun, A Hong, Z Hassan, C Wong, S Halpern. Originally published in Iproceedings (https://www.iproc.org), 10.12.2021.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in Iproceedings, is properly cited. The complete bibliographic information, a link to the original publication on https://www.iproc.org/, as well as this copyright and license information must be included.